Patient Navigation in Cancer Survivorship at a Safety Net Institution

Patient Navigation as Part of the Cancer Survivorship Care Plan at a Safety Net Institution

This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan.

This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan.

Study participation for all participants will be for up to 9 months, with study visits approximately every 3 months, based on standard clinical follow-up. All participants will be administered quality of life surveys by a Clinical Research Associate at study entry, mid-study (approximately 3-6 months) and at study completion.

The following factors will be compared between arms:

• Missed/kept appointments
• Use of urgent/emergent care
• Quality of Life in relation to survivorship care
• Participants lost to care

Inclusion Criteria:

• Stage I, II, III or IVa Cancer diagnosis (may include Solitary plasmacytoma, Diffuse Large B-Cell Lymphoma (DLBCL), ductal carcinoma in situ (DCIS) of the breast)
• Completed treatment with curative intent within the past 12 months. (May be on maintenance therapy.)

Exclusion Criteria:

• Distant Metastatic disease
• Non-curable disease
• Recurrence of disease prior to enrollment
• Require ongoing navigation from the treatment navigator
• Enrolled/active in another randomized study (Project SUPPORT)